← Back to Intel
Insider ActivityXFOR
KIRSKE DAVID, Chief Financial Officer at X4 Pharmaceuticals, Inc, sold $73K of XFOR
Updated Jun 16, 2026
KIRSKE DAVID
Chief Financial Officer
X4 Pharmaceuticals, Inc ·
$XFOR
Transaction Details
| Insider | KIRSKE DAVID |
|---|---|
| Title | Chief Financial Officer |
| Company | X4 Pharmaceuticals, Inc |
| Ticker | XFOR |
| Transaction Type | Sale |
| Transaction Date | 2026-05-12 |
| Shares Traded | 16,961 |
| Price Per Share | $4.2934 |
| Total Value | $73K |
| Filed Date | 2026-05-13 |
| Accession Number | 0001501697-26-000049 |
Ownership Context
| Shares Owned After Transaction | 176,293 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001501697-26-000049
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for XFOR — X4 Pharmaceuticals, Inc →
Track XFOR insider activity in real time on The Wire →
Get alerts when KIRSKE DAVID files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 16, 2026 at 07:11 UTC